For the Quarter Ending June 2026
Dolutegravir Prices in APAC
- In India, the Dolutegravir Price Index rose by 0.09% quarter-over-quarter, reflecting offsetting supply and demand signals.
- The average Dolutegravir price for the quarter was approximately USD 168849.80/MT, reflecting mixed monthly directional shifts.
- Dolutegravir Spot Price softened in June as excess ex-works volumes slightly eased the Price Index.
- Dolutegravir Price Forecast points to modest third-quarter recovery contingent on timely restocking and institutional purchases.
- Dolutegravir Production Cost Trend eased as Chinese intermediate declines reduced conversion expenses and marginal costs.
- Dolutegravir Demand Outlook remains mixed with institutional tenders lifting orders, while private purchasing delays persist.
- Inventory accumulation in May and increased Hyderabad output pressured the Dolutegravir Price Index, prompting discounts.
- Producers kept high operating rates and extended warehouse cover, encouraging widened ex-works concessions to clear supply.
Why did the price of Dolutegravir change in June 2026 in APAC?
- Fresh Hyderabad and Visakhapatnam capacity additions created an export-oriented surplus, pressuring domestic ex-works realizations immediately.
- Chinese intermediate supplies remained ample, lowering conversion costs and enabling suppliers thus to concede discounts.
- Institutional buyers secured allocations, reducing export spot demand while manufacturers' inventories climbed, limiting fresh purchases.
Dolutegravir Prices in Europe
- In Germany, the Dolutegravir Price Index held steady quarter-over-quarter, supported by predictable import flows and balanced institutional procurement.
- The average Dolutegravir cost for the quarter reflected stable Asian supply and consistent landed-cost structures into major EU distribution hubs.
- Dolutegravir Spot Price softened slightly in June as distributors prioritized inventory normalization and avoided speculative purchases.
- Dolutegravir Price Forecast indicates modest third-quarter improvement tied to tender cycles and replenishment by public-health programs.
- Dolutegravir Production Cost Trend eased as lower Chinese intermediate values reduced conversion costs for European importers.
- Dolutegravir Demand Outlook remained mixed, with institutional tenders supporting volumes while private-sector purchasing stayed cautious.
- Inventory accumulation in May and steady German formulation output pressured the Dolutegravir Price Index, prompting selective discounts.
- Producers maintained high operating rates, sustaining supply depth and encouraging modest ex-works concessions to clear accumulated stock.
Why did the price of Dolutegravir change in June 2026 in Europe?
- Ample Asian intermediate availability lowered conversion costs, enabling European importers to negotiate slight June concessions.
- German distributors reduced forward purchases due to inventory carryover, softening spot demand and pressuring June realizations.
- Institutional procurement remained stable, but private-sector delays limited fresh orders, preventing upward movement in June.
Dolutegravir Prices in North America
- In the US, the Dolutegravir Price Index remained broadly stable quarter-over-quarter, reflecting balanced import volumes and steady institutional demand.
- The average Dolutegravir cost for the quarter mirrored consistent Asian supply and predictable landed-cost conditions across major US ports.
- Dolutegravir Spot Price softened in June as distributors avoided excess stocking amid uneven private-sector purchasing.
- Dolutegravir Price Forecast suggests modest Q3 recovery driven by federal program restocking and improved procurement visibility.
- Dolutegravir Production Cost Trend eased as Chinese intermediate declines filtered into US landed-cost structures.
- Dolutegravir Demand Outlook stayed mixed, with institutional programs supporting baseline volumes while commercial buyers delayed replenishment.
- Inventory accumulation in May and steady US formulation output created mild downward pressure on the Dolutegravir Price Index.
- High operating rates among Asian producers sustained supply depth, narrowing arbitrage and encouraging selective discounts.
Why did the price of Dolutegravir change in June 2026 in North America?
- Ample Asian supply and lower intermediate costs enabled US buyers to secure modest June discounts.
- Private-sector purchasing delays reduced spot demand, pressuring ex-works realizations and limiting upward momentum.
- Institutional allocations were secured earlier in the quarter, reducing June procurement activity and softening price sentiment.
For the Quarter Ending March 2026
Dolutegravir Prices in APAC
- In India, the Dolutegravir Price Index fell by 0.56% quarter-over-quarter, reflecting marginal net softening across Q1.
- The average Dolutegravir price for the quarter was approximately USD 168696.16/MT, on an ex-works basis.
- Dolutegravir Spot Price firmed in March amid export pull and constrained Hyderabad operating days, tightening immediate availability.
- Dolutegravir Price Forecast suggests modest near-term gains as replenishment orders and export enquiries outweigh limited incremental supply.
- Dolutegravir Production Cost Trend remained stable because Chinese fluorinated intermediate quotations held flat, limiting conversion cost inflation.
- Dolutegravir Demand Outlook turned firmer as African procurement pulled forward shipments and India issued additional replenishment orders.
- Dolutegravir Price Index volatility increased due to compliance audits reducing operating days and lowering effective warehouse cover.
- Major Hyderabad producers prioritized export allocations, keeping domestic lead times stretched and supporting temporary upward pricing pressure.
Why did the price of Dolutegravir change in March 2026 in APAC?
- Supply disruptions from Telangana compliance audits reduced operating days, tightening short-term availability and supporting price increases.
- Re-routing vessels around the Red Sea lengthened sailing times and raised insurance premiums, marginally increasing landed costs.
- Buyers pulled forward orders ahead of the fiscal-year close while inventories tightened, creating stronger short-term export demand.
Dolutegravir Prices in North America
- In the USA, the Dolutegravir Price Index showed marginal softness quarter-over-quarter, reflecting stable supply availability and balanced procurement flows.
- Dolutegravir Spot Price firmed in March as tighter export allocations from India and reduced operating days at key suppliers constrained immediate availability.
- Dolutegravir Production Cost Trend remained broadly stable, as upstream fluorinated intermediate prices stayed flat, limiting cost-side inflation.
- Dolutegravir Demand Outlook strengthened, supported by steady HIV treatment programs and replenishment-driven procurement from healthcare systems and distributors.
- Dolutegravir Price Forecast indicates mild upward pressure in the near term, driven by export disruptions and scheduled replenishment cycles.
- Inventory levels in distribution channels tightened slightly due to delayed shipments and stronger-than-expected March procurement.
- Import lead times increased due to supply-side disruptions in Asia and extended logistics routing via alternative shipping lanes.
- Suppliers maintained firmer pricing on spot volumes, reflecting tighter export availability and improved bargaining strength.
Why did the price of Dolutegravir change in March 2026 in North America?
- Reduced operating days in India due to compliance audits limited export supply, tightening US availability.
- Longer shipping routes and higher freight and insurance costs increased landed import expenses.
- Accelerated procurement from healthcare systems ahead of fiscal cycles strengthened short-term demand pressure.
Dolutegravir Prices in Europe
- In Germany, the Dolutegravir Price Index remained broadly stable to slightly softer quarter-over-quarter, reflecting balanced regional supply and demand conditions.
- Dolutegravir Spot Price firmed in March as constrained Indian exports and longer shipping durations reduced immediate availability.
- Dolutegravir Production Cost Trend stayed stable, supported by flat intermediate costs and limited upstream volatility.
- Dolutegravir Demand Outlook strengthened slightly, driven by consistent HIV treatment programs and public healthcare procurement.
- Dolutegravir Price Forecast suggests mild firmness, as temporary supply tightness is expected to outweigh subdued demand growth.
- Inventory levels across European distribution hubs tightened modestly due to delayed arrivals and steady consumption.
- Import flows were affected by extended transit times and rerouting through alternative maritime corridors.
- Suppliers maintained selective allocation strategies, prioritizing contracted buyers and limiting spot availability.
Why did the price of Dolutegravir change in March 2026 in Europe?
- Compliance-related production slowdowns in India reduced export availability, tightening European supply.
- Longer shipping routes and higher logistics costs increased landed prices into Europe.
- Forward purchasing ahead of fiscal cycles and delayed arrivals reduced inventories, supporting firmer spot conditions.
For the Quarter Ending December 2025
Dolutegravir Prices in APAC
- In India, the Dolutegravir Price Index fell by 0.64% quarter-over-quarter, reflecting softer export call-offs nationwide.
- The average Dolutegravir price for the quarter was approximately USD 169653.06/MT, with balanced institutional demand.
- Dolutegravir Spot Price remained near monthly averages as Hyderabad production and logistics maintained steady supply.
- Dolutegravir Price Forecast shows mild year-end softness then modest export-driven support into early next quarter.
- Dolutegravir Production Cost Trend stayed broadly flat as key fluorinated intermediate prices remained stable month-on-month.
- Dolutegravir Demand Outlook remained steady with NACO and Global Fund orders absorbing substantial Indian export volumes.
- Dolutegravir Price Index reflected mild downward pressure as inventories rose and producers offered small rebates.
- Operational capacity additions in Hyderabad and Visakhapatnam eased tightness, prompting competitive pricing to clear inventory.
Why did the price of Dolutegravir change in December 2025 in APAC?
- Incremental output from Hyderabad and Visakhapatnam increased supply, easing spot tightness and pressuring prices modestly.
- Export call-offs reduced after major Global Fund cycle, lowering overseas demand and softening ex-works prices.
- Stable fluorinated intermediate costs and smooth logistics limited input inflation, enabling producers to concede discounts.
Dolutegravir Prices in Europe
- In Europe, the Dolutegravir Price Index edged slightly lower quarter-over-quarter, reflecting softer import call-offs from regional buyers.
- Dolutegravir market conditions remained import-led, with shipments from Indian manufacturers largely meeting European demand.
- Dolutegravir Spot Price stayed near monthly averages, as steady port arrivals and distributor inventories balanced short-term needs.
- Dolutegravir Price Forecast indicates mild near-term softness, with gradual support expected from renewed institutional orders in early 2026.
- Dolutegravir Production Cost Trend for importers remained stable, as landed costs were largely aligned with steady Indian export pricing.
- Dolutegravir Demand Outlook stayed balanced, with European health programs and private procurement absorbing standard volumes.
- Dolutegravir Price Index reflected minor downward pressure, as distributors held adequate stocks and exercised selective buying.
- Smooth logistics and consistent supply flows from India helped maintain market stability, preventing sharp price movements.
Why did the price of Dolutegravir change in December 2025 in Europe?
- Softer European call-offs reduced immediate import demand, applying mild downward pressure on landed prices.
- Steady Indian supply ensured consistent arrivals, keeping spot tightness minimal.
- Stable landed costs and reliable logistics allowed distributors to manage inventories without urgent price adjustments.
Dolutegravir Prices in North America
- In North America, the Dolutegravir Price Index showed mild quarter-over-quarter softness, influenced by steady import availability and balanced institutional demand.
- Dolutegravir market conditions remained import-led, with Indian-origin shipments supplying key government and healthcare programs.
- Dolutegravir Spot Price stayed near monthly averages as distributors maintained adequate inventory, limiting immediate pricing pressure.
- Dolutegravir Price Forecast anticipates modest recovery in early 2026, supported by renewed Global Fund and institutional procurement cycles.
- Dolutegravir Production Cost Trend for importers remained stable, as landed costs were steady due to consistent overseas intermediate pricing and predictable freight.
- Dolutegravir Demand Outlook remained firm, driven by government healthcare programs, NGO purchases, and consistent ART program consumption.
- Dolutegravir Price Index reflected mild downward pressure in December as distributors drew from existing inventories and negotiated term discounts.
- Smooth port operations and reliable logistics supported timely deliveries, reducing urgency-driven spot premiums.
Why did the price of Dolutegravir change in December 2025 in North America?
- Adequate Indian exports ensured supply coverage, limiting upward price pressure and softening spot activity.
- Reduced year-end call-offs from institutional buyers eased immediate demand, contributing to mild price declines.
- Stable landed costs and consistent logistics prevented input-driven cost escalation, allowing distributors to maintain negotiated offers.
For the Quarter Ending September 2025
APAC
- In India, the Dolutegravir Price Index fell by 2.76% quarter-over-quarter, reflecting reduced production costs and inventory.
- The average Dolutegravir price for the quarter was approximately USD 170746.69/MT, reflecting inventory cost influences.
- Dolutegravir Spot Price remained subdued as Chinese API oversupply lowered input costs influencing the Price Index downward.
- Dolutegravir Production Cost Trend showed moderation due to falling API costs and improved plant efficiency.
- Dolutegravir Demand Outlook remained cautious with conservative procurement and high supplier inventories limiting fresh order volumes.
- Dolutegravir Price Forecast indicates recovery as restocking and steady pharmaceutical demand support upward price adjustments.
- Dolutegravir Price Index stability depended on inventory normalization, export demand pickup, and reliable plant operations.
- Currency-driven import pressures and higher Chinese API quotations pushed costs, affecting overall Dolutegravir Spot Price.
Why did the price of Dolutegravir change in September 2025 in APAC?
- Chinese API availability tightened and higher export quotations increased imports costs and domestic production pressure.
- High supplier inventories and conservative procurement restrained demand, leading to softer Price Index and weaker offtake.
- Improved logistics and plant efficiencies lowered manufacturing expenses, offsetting cost inflation and moderating price changes.
Europe
- In the Netherlands, the Dolutegravir Price Index declined quarter-over-quarter, primarily due to softer import quotations and stable regional inventory levels.
- Dolutegravir Spot Price remained subdued as abundant API supply from Asia and moderate restocking activity limited upward price movement.
- Dolutegravir Price Forecast suggests near-term stabilization, supported by seasonal restocking and consistent pharmaceutical formulation requirements across Europe.
- Dolutegravir Production Cost Trend for importers reflected easing input costs and favorable freight adjustments, lowering overall landed costs.
- Dolutegravir Demand Outlook remained cautious, with steady consumption from pharmaceutical end-users and distributors maintaining lean inventories.
- Price Index movement was influenced by reduced procurement urgency, normalized logistics, and steady API inflows from Asian exporters.
- Stable domestic operations and predictable shipping schedules minimized volatility, maintaining balanced pricing throughout the quarter.
- Limited demand growth and competitive import offers kept transaction levels moderate, restraining significant price fluctuations in the regional market.
Why did the price of Dolutegravir change in September 2025 in Europe?
- Lower Asian export quotations and favorable freight rates reduced landed costs, exerting downward pressure on the Dolutegravir Price Index.
- Adequate inventories and steady but cautious procurement activity limited immediate restocking demand across major European buyers.
- Softer API costs from China and India combined with stable logistics lowered overall import expenses, moderating price movement during the month.
North America
- In the USA, the Dolutegravir Price Index declined quarter-over-quarter, driven by lower import quotations and steady supplier availability.
- Dolutegravir Spot Price softened as global API oversupply and moderated export quotations from Asia reduced landed import costs.
- Dolutegravir Price Forecast indicates potential stabilization in early Q4, supported by restocking and steady pharmaceutical formulation demand.
- Dolutegravir Production Cost Trend for importers remained moderate, reflecting lower input costs and improved supply chain efficiency.
- Dolutegravir Demand Outlook stayed cautious, with procurement aligned to existing inventory levels and stable production across key formulators.
- Price Index movements were influenced by subdued import demand, favorable freight trends, and consistent API availability from Asian suppliers.
- Distributor inventories remained sufficient, reducing the urgency for bulk purchases and maintaining a balanced supply-demand environment.
- Reliable logistics and stable import flows kept market volatility low, supporting predictable price behavior through the quarter.
Why did the price of Dolutegravir change in September 2025 in North America?
- Softer API offers from Asian producers lowered landed import costs, pressuring domestic pricing levels.
- Adequate inventories and measured procurement from pharmaceutical manufacturers limited upward momentum in spot prices.
- Improved logistics and favorable freight rates further reduced landed costs, reinforcing a subdued pricing environment.
